|
|
Micro-randomized trial of a physical activity intervention to manage pain symptoms among older cancer survivors |
| 1K01CA255414-01A1 |
|
NCI |
2022 |
|
|
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial |
| 5R01CA237892-03 |
|
NCI |
2022 |
|
|
Development of A HTLV-1 Vaccine |
| 1 R01 CA252049-01A1 |
BARBER, GLEN N |
NCI |
2021 |
|
|
Therapeutic potential of targeting DNA repair deficiency in TSC |
| 1 R21 CA263133-01 |
|
NCI |
2021 |
|
|
Career Enhancement Program
[Parent Title: Mayo Clinic Ovarian Cancer SPORE] |
| 2 P50 CA136393-11A1 |
COUCH, FERGUS JOSEPH |
NCI |
2021 |
|
|
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial |
| 5 R01 CA237892-02 |
|
NCI |
2021 |
|
|
MRI study of chemobrain in pediatric oncology patients |
| 5 R01 CA244768-02 |
|
NCI |
2021 |
|
|
Outreach Core |
| 5 U54 CA202995-07 |
|
NCI |
2021 |
|
|
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy |
| 5R01CA221363-03 |
COPE, TIMOTHY C |
NCI |
2020 |
|
|
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to Phase III Study |
| 5R01CA235726-02 |
SMITH, ELLEN MARY LAVOIE |
NCI |
2020 |
